Articles From: Octagon 88 Resources Releases Bluesky Gething Drilling Video to Odyssey Marine Exploration Reports Second Quarter 2014 Results


Octagon 88 Resources Inc. , (OCTX) is pleased to present the Bluesky Gething drilling video.
Sign-up for Octagon 88 Resources Releases Bluesky Gething Drilling Video investment picks
2014/10/2
October Events! Justin Trudeau in Conversation With Heather Reisman, Bobby Orr, Chris Hadfield and IndigoKids Open House Canada NewsWire OCTOBER EVENTS AT INDIGO BOOKS & MUSIC TORONTO , Oct.
Sign-up for October Events! Justin Trudeau in Conversation With Heather Reisman, Bobby Orr, Chris Hadfield and IndigoKids Open House investment picks
ADVISORY, July 31, 2014 (GLOBE NEWSWIRE) -- What: Ocular Therapeutix (Nasdaq:OCUL) , a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, will visit the NASDAQ MarketSite in Times Square in celebration of its initial public offering (IPO) which occurred on The NASDAQ Stock Market on July 25, 2014.
Sign-up for Ocular Therapeutix (NASDAQ: OCUL) to Ring The NASDAQ Stock Market Closing Bell investment picks
Ocular Therapeutix (Nasdaq: OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, announced today the closing of its initial public offering of 5,000,000 shares of its common stock at a public offering price of $13.00 per share, resulting in net proceeds of approximately $60.5 million after deducting underwriting discounts and commissions, and estimated offering expenses.
Sign-up for Ocular Therapeutix Announces Closing of Initial Public Offering investment picks
Ocular Therapeutix (Nasdaq: OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, announced today that the underwriters of its initial public offering have exercised in full their over-allotment option to purchase an additional 750,000 shares at the initial public offering price of $13.00 per share, less underwriting discounts.
Sign-up for Ocular Therapeutix Announces Exercise of Over-Allotment Option investment picks
Ocular Therapeutix (Nasdaq: OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced financial results for the second quarter ended June 30, 2014.
Sign-up for Ocular Therapeutix Announces Second Quarter 2014 Financial Results investment picks
2014/7/24
Ocular Therapeutix, a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, announced today the pricing of its initial public offering of 5,000,000 shares of its common stock at a public offering price of $13 per share, before underwriting discounts and commissions.
Sign-up for Ocular Therapeutix Prices Initial Public Offering investment picks
Ocular Therapeutix (Nasdaq: OCUL) today announced that Amar Sawhney, Ph.D., President and Chief Executive Officer, will present a corporate overview at the Morgan Stanley 2014 Global Healthcare Conference.
Sign-up for Ocular Therapeutix to Present at Morgan Stanley 2014 Global Healthcare Conference investment picks
Ocular Therapeutix (Nasdaq: OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced that Amar Sawhney, Ph.D., President and Chief Executive Officer, will provide an overview of the Company at the 21st Annual BioCentury Conference during a live presentation at 3:30pm ET on September 26, 2014.
Sign-up for Ocular Therapeutix to Present at the 21st Annual NewsMakers in the Biotech Industry Investment Conference on Friday, September 26 investment picks
Ocular Therapeutix, Inc. (NASDAQ: OCUL) announced today completion of enrollment for its two Phase 3 clinical trials evaluating Sustained Release Dexamethasone (OTX-DP) for treatment of ocular inflammation and pain following cataract surgery.
Sign-up for Ocular Therapeutix™ Completes Enrollment in Phase 3 Sustained Release Dexamethasone Trials for Post-Operative Inflammation and Pain investment picks
PETALUMA, Calif., July 24, 2014 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) , today announced that the financial results for its fiscal first quarter 2015, ended June 30, 2014, will be released after the U.S. markets close on August 7, 2014.
Sign-up for Oculus Innovative Sciences Announces Fiscal First Quarter 2015 Financial Results and Conference Call investment picks
Net loss of $70,000, reduced $1.6 million from same period last year Oculus owns two million shares of Ruthigen (Nasdaq:RTGN) Net worth of $13.4 million, up $10.8 million from June 30, 2013 Cash position of $5 million with $64,000 in debt Conference Call Begins at 4:30 p.m. (EDT) Today PETALUMA, Calif., Aug.
Sign-up for Oculus Innovative Sciences Reports Revenues of $3.4 Million and Net Loss of $70,000 for First Quarter of Fiscal 2015 investment picks
U.S. Patent for Treatment of Second- and Third-Degree Burns; U.S. and Canadian Patents for Treatment of Peritonitis; Chinese Patent for Solution Containing Hypochlorous Acid and Its Methods of Use PETALUMA, Calif., Sept.
Sign-up for Oculus Innovative Sciences Strengthens Intellectual Property Portfolio With Allowance of Four New Patents for Microcyn(R) Technology investment picks
Ocwen Financial Corporation (NYSE:OCN) CEO Ronald Faris yesterday addressed the National Foundation for Credit Counseling (NFCC)’s 49 th Annual Leaders Conference.
Sign-up for Ocwen CEO Ronald Faris Addresses National Foundation for Credit Counseling investment picks
WASHINGTON, July 16, 2014 (GLOBE NEWSWIRE) -- Ocwen Financial Corporation (NYSE:OCN) , the nation's fourth largest mortgage servicer, today announced the creation of a Community Advisory Council (the "Council"). The Council will provide a forum for Ocwen leaders and community advocates to share ideas, discuss policy issues and collaboratively identify opportunities for Ocwen to have a positive impact on local communities, particularly those hit hardest by the economic downturn.
Sign-up for Ocwen Creates Community Advisory Council investment picks
Income from operations up 22% to $207.6 million Over $200 million returned to shareholders through buybacks since April 1, 2014 ATLANTA, July 31, 2014 (GLOBE NEWSWIRE) -- Ocwen Financial Corporation, (NYSE:OCN) , a leading financial services holding company, today reported Net income of $67.0 million, or $0.48 per share, for the second quarter of 2014 compared to Net income of $76.7 million, or $0.53 per share, for the second quarter of 2013.
Sign-up for Ocwen Financial Announces Operating Results for Second Quarter 2014 investment picks
ATLANTA, July 14, 2014 (GLOBE NEWSWIRE) -- Ocwen Financial Corporation, (NYSE:OCN) , a leading financial services holding company, announced that earlier today the 62,000 outstanding shares of its Series A Perpetual Convertible Preferred Stock ("Preferred Stock") were converted into common stock and immediately repurchased and cancelled.
Sign-up for Ocwen Financial Announces Repurchase From WL Ross & Co. Managed Funds investment picks
Former United States Securities and Exchange Commission attorney Willie Briscoe , founder of The Briscoe Law Firm, PLLC , and the securities litigation firm of Powers Taylor LLP announce that a federal class action lawsuit has been filed against Ocwen Financial Corporation (“Ocwen” or “Company”) (NYSE: OCN) and several officers and directors for acts taken during the period of May 2, 2013 to August 11, 2014 (the “Class Period”). Based upon the allegations in the class action, the firms are investigating additional legal claims against the officers and Board of Directors of Ocwen.
Sign-up for Ocwen Financial Corp Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors investment picks
ATLANTA, July 22, 2014 (GLOBE NEWSWIRE) -- Ocwen Financial Corporation (NYSE:OCN) will hold its conference call on Thursday, July 31, 2014 at 11:00 a.m. (ET) to review the Company's operating results.
Sign-up for Ocwen Financial Corporation Schedules Conference Call - 2nd Quarter 2014 Results investment picks
Ocwen Financial Corporation (NYSE:OCN), the nation’s fourth largest mortgage servicer, today held the first meeting of the company’s Community Advisory Council (the “Council”) at the Capital Hilton in Washington, DC.
Sign-up for Ocwen Holds First Community Advisory Council Meeting investment picks
Ocwen Financial Corporation (NYSE:OCN) , the nation’s largest independent mortgage servicer, announced today that it received 3-Star ratings, the highest rating possible, in all categories in the quarterly compliance review report issued on September 5, 2014 by Making Home Affordable-Compliance (MHA-C). MHA-C is the Compliance Agent responsible for evaluating and reporting to the U.S. Department of the Treasury on participating Mortgage Servicers’ HAMP compliance.
Sign-up for Ocwen Receives Highest Possible Rating in All Categories in 2Q 2014 Treasury HAMP Compliance Assessment Review investment picks
15,500+ Gold and Silver Coins, 45 Gold Bars Recovered To-Date; TAMPA, Fla., Sept.
Sign-up for Odyssey Marine Exploration Completes Current Phase of SS Central America Recovery investment picks
TAMPA, Fla., Oct.
Sign-up for Odyssey Marine Exploration Implements Planned Management Transition investment picks
TAMPA, Fla., Aug.
Sign-up for Odyssey Marine Exploration Reports Second Quarter 2014 Results investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Octagon 88 Resources Releases Bluesky Gething Drilling Video to Odyssey Marine Exploration Reports Second Quarter 2014 Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices